We are live on ! Find out more
MGCD

MGC Diagnostics
MGCD

Delisted

MGCD was delisted on the 28th of December, 2017.

12 hedge funds and large institutions have $4.23M invested in MGC Diagnostics in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

14.59% less ownership

Funds ownership: 23.29% → 8.7% (-15%)

37% less funds holding

Funds holding: 19 → 12 (-7)

67% less capital inflows, than outflows

Capital inflows: $2.78M | Capital outflows: $8.37M

70% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 10

Holders
12
Holders Change
-7
Holders Change %
-36.84%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
1
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

MGCD Hedge Fund Activity: Q4 2017 in Review

12 of the 4,418 institutional investors tracked by Wall St. Rank reported a position in MGC Diagnostics (MGCD) for Q4 2017, worth a combined $4.23M — down 54% from $9.21M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of MGCD and 3 opened new positions — a net loss of 7 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was Kennedy Capital Management, opening a new position worth an estimated $2.21M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $2.59M sold.

  • 12 institutional investors held MGC Diagnostics (MGCD) as of Q4 2017, down from 19 in Q3 2017.
  • Funds reported $4.23M of MGC Diagnostics stock for Q4 2017, down 54% quarter-over-quarter.
  • 3 funds opened new MGC Diagnostics positions in Q4 2017 and 10 closed out, a net change of -7 holders.
  • The largest MGC Diagnostics buyer in Q4 2017 was Kennedy Capital Management, an estimated $2.21M added.
  • The largest MGC Diagnostics seller in Q4 2017 was Renaissance Technologies, an estimated $2.59M sold.

Based on aggregated 13F filings for Q4 2017.